Digging into Tessera Technologies: Smaller, Faster, Smarter
-
Font Size:
Tessera is all about making semiconductor packaging technology that allows its customers to produce semiconductors that are smaller, faster and smarter than competitors' chips. It generates revenues from license fees and royalties based on intellectual property it develops.
What is of special interest is two groups of shareholders: Morgan Stanley has a little more than 10% of the stock and Goldman Sachs owns a bit more than 14% (as of April of 2006). Officers and directors have 5%. When two large and respected Wall Street firms take a position of this magnitude in a publicly traded stock, it usually means the stock is worth spending time with and maybe money as well.
Here are some impressive numbers for TSRA. Net Profit Margin for 2004 was 81%, then it was 33%, followed by 29%. Look for 23% this year and 28.5% next year. Return on equity for the trailing twelve months was almost 25%. There is no debt on the books. Analysts expect sales to grow, on average, 26.5% per year over the next 5 years while earnings are forecast to increase by 19% per year, on average, in the same time frame.
Tessera receives licensing revenues from almost 80% of the DRAM (dynamic random access memory) manufacturers. It has developed something called CSP technology which is incorporated into DDR2 memory. Over the last year, demand for the chip has grown by double digits. The new DDR3 market is just emerging which will most likely carry the CSP technology. Furthermore, the new Vista operating system will increase demand for more DRAM.
Tessera generates a lot of cash. It's using some of it to buy other companies. Earlier this year, it acquired Eyesquad. The company is a leader in digital focus and optic zoom soutions for electronic products using cameras, in particular cellphones. Analysts estimate that volumes in the digital imaging market are likely to grow beyond 1 billion units by 2010.
Lawsuits have been a big part of Tessera's past and this year. That should decrease next year and going forward. Most of these suits deal with collecting royalty fees. One in particular against Amkor will last through 2007 and another involving several other parties looks like it won't be done until next year. The legal fees are high, but the royalties being sought will not only cover those fees but warn others not paying for the intellectual property they're using.
Tessera has a bright future. Its CSP technology is in high demand which will keep license revenues strong. The balance sheet is clean with no debt and $220 million in cash. Current liabilities are only $15.4 million.
Spend some time digging into TSRA if you're looking for a tech stock. This one holds some good nuggets and has a great story. Of course all the positive news hasn't been kept from investors. They've bid up the stock so it's carrying a rather high P/E of 33.
TSRA 1-yr chart
Disclosure: none
Get Seeking Alpha Free Stock Alerts by Email!
Get Free Stock Alerts by Email!
-
Editor's Picks
-
Most Popular
- Assurant Is A Compelling Short Sell
- Broadcom Enters FTTH Chipset Market
- Another Macroshares Oil Arbitrage Opportunity
- Freeport McMoran: With Copper Prices Rising, It's Still a Buy
- Oil and the Futures Market
- Three Ways to Cash In on Record Meat and Dairy Prices
- Full list of Editor's Picks »
- High Likelihood of a Market Crash »
- Time To Start Buying Some Dogs? »
- Sirius-XM Combination: A Future Microsoft Acquisition? »
- JP Morgan Offer for Wachovia Makes Sense »
- High-Yield Canadian Royalty Trusts: What's the Catch? »
- Adding to My GE Position »
- 7 Stocks for a High Yield Cash Flow Portfolio »
- Drybulk Shipping: Prepare for a New Record High »
- Nokia: Bargain of a Lifetime - Barron's »
- Top 10 Payout Yield Stocks »
- Wall Street Breakfast: Must-Know News »
-
Long Ideas
-
Short Ideas
-
Cramer's Picks
- Adding Wood to Your Portolio: A Worthwhile Investment
- Arkansas Steel: 10 Structural Changes That Should Trump the Business Cycle
- Gross Margin Drivers at Potash Corp. (Part II)
- A New Strategy for EXACT Sciences
- Cytori Therapeutics: The Stem Cell 'Celution' for Success
- LDK Solar: The Brightest Opportunity?
- Big Lots, Wal-Mart and Costco: 3 Musketeers of the Pooring of America
- What's Behind Hansen's Smackdown?
- The Long Case for China Medical Technologies
- ASA Limited: A Golden Opportunity
- Full list of Long Ideas »
- Crystal River’s Q2 Write-Downs Could Bankrupt the Company
- Assurant Is A Compelling Short Sell
- Fuel Systems Solutions: Time to Take Profits
- GM an Unlikely Hero - Fast Money Recap (7/1/08)
- Pair Trade Visa and Capital One
- Amazon's Kindle Numbers: All Fluff, Zero Substance
- A. Schulman: Cashless Profits
- Titan Machinery: Doesn't Anybody Look at Valuation?
- Goodrich Petroleum: Gas in the Ground Doesn't Mean Cash in the Bank
- Outlook Remains Grim for MBIA, Ambac
- Full list of Short Ideas »
- StanCorp a Safe Financial - Cramer's Lightning Round (7/2/08)
- Momentum Stocks Stalled - Cramer's Stop Trading! (7/3/08)
- Expecting a Lift for Pediatrix: Cramer's Mad Money (7/3/08)
- The Most Bullish Thing - Cramer's Stop Trading! (7/1/08)
- Exelon's Got Nukes - Cramer's Lightning Round (7/1/08)
- Prescription Prediction for Allscripts - Cramer's Mad Money (7/1/08)
- Rex Marks the Spot - Cramer's Lightning Round, (6/30/08)
- Medicare Bill Buys - Cramer's Mad Money (6/30/08)
- Cracker Bottom of the Barrel - Cramer's Lightning Round (6/27/08)
- Britannia Bulk Rules the Waves - Cramer's Mad Money (6/27/08)
- Full list of Cramers Picks »
Most Popular Feeds
-
ETFs
-
US Market
-
Long Ideas
-
Alt. Energy
- Full list of feeds »
Hedge Fund Jobs
Job Seekers:
- Search jobs by category
- Get job alerts by email or live feed
- Apply online
Employers
- See all recruitment options
- Get applications online or by email


